Navigation Links
Professor Develops Blood Test for Alzheimer’s Disease Risk
Date:7/29/2014

Pomona, California (PRWEB) July 29, 2014

A team of scientists, led by Western University of Health Sciences Professor Doug Ethell, PhD, has developed a blood test for Alzheimer’s disease risk that may lead to earlier detection and the development of Alzheimer’s disease interventions, according to an article published July 29, 2014.

“Alzheimer’s disease is a puzzle, and this study represents one of several pieces that have locked into place for us over the past couple of years,” Ethell said.

The study, “Women with the Alzheimer's risk marker ApoE4 lose Aß-specific CD4+ T cells 10-20 years before men,” describes how the new test gauges the immune responses to a component of brain plaques associated with the disease. Carriers of the Alzheimer’s risk factor ApoE4 showed an earlier decline in this response than non-carriers, by about a decade.

Women showed an earlier decline than men, which is consistent with a 2.5-fold higher risk of Alzheimer’s disease. Women who carried ApoE4 showed the earliest decline of any group, with a precipitous drop found between the ages of 45 and 52, when menopause typically begins.

Aß-specific CD4+ T cells have a central role in regulating adaptive immune responses to antigens, and have been shown to reduce AD pathology in mouse models. As these cells may facilitate endogenous mechanisms that counter AD, an evaluation of their abundance before and during AD provides important insights, according to the study.

“It’s very exciting because it changes the way we think about this disease, and opens the door to some interesting possibilities,” Ethell said.

The assay may provide an early indicator of changes that precede Alzheimer’s disease by a decade or more by quantifying Aß-specific CD4+ T cells in human blood. This assay, called CD4see, could accelerate clinical testing of new Alzheimer’s disease interventions that require an early biomarker.

“Our team is very close to figuring out the cause of Alzheimer’s disease,” Ethell said. “We are working on the next piece and if that falls into place, we could be treating early- and middle-stage Alzheimer’s disease patients within three to five years.”

The article was published in Translational Psychiatry, from Nature Publishing Group. Click here to view the article: http://www.nature.com/tp/journal/v4/n7/full/tp201451a.html.

Read the full story at http://www.prweb.com/releases/2014/07/prweb12055740.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Louisiana Tech University professor earns NSF Early Career Development grant
2. Clemson professor awarded nearly $600,000 4-year grant to study language of plants
3. Louisiana Tech biomedical engineering professor earns recognition, funding for research
4. Women professorships low in some Scandinavian universities due to sexism
5. President Obama names SF State math professor a top young scientist
6. From textbook to flexbook: Professor uses new collaborative tool in the classroom
7. IHME professor named first health measurement winner of prestigious innovation award
8. Guys, take note: Male birth control pill may be ready soon, says Texas A&M professor
9. UBC professor wins Canadas top pharmaceutical research award
10. Huddersfield professors ground-breaking research shows just how well the 2012 Games were run
11. Grove Professor receives $1.5MM to study breast cancer therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Revolution for Truth ... Congress to protect parental rights and civil liberties, and to restore transparency within ... The demonstration coincides with a press conference taking place Friday morning calling on ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... of all holidays (IBT World Travel Trends Report). As travelers visit both urban ... range in temperatures, and prolonged sun exposure. In response, the outdoor industry has ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... announced today the launch of a free, public-facing tool for analyzing the costs ... was developed to provide comparative information to patients, providers, insurers and pharmaceutical companies ...
(Date:3/28/2017)... ... ... WHO: , Dr. Paul Thomas; Dr. Brian Hooker; Dr. Judy Mikovits; Dr. Jennifer ... speak to the press on behalf of over 200 doctors, scientists, and scientific organizations ... , WHERE: , Zenger Room, National Press Club, 529 14th Street NW, 13th ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... laboratory instruments are critical to ensuring high-quality results and maintaining GMP and USP ... of Laboratory Instruments in accordance with GMP requirements " these requirements are explained. ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... KALAMAZOO, Michigan , USA, March 29, 2017 /PRNewswire/ ... a Company that Cares by People magazine, in partnership ... out of 50 companies on the list. This list ... employees that have succeeded in business while also demonstrating ... and the environment.  To determine the ...
(Date:3/29/2017)... FinancialBuzz.com News Commentary  ... Data published in a research report by Grand View Research, Inc., projects ... 55.8 billion by 2025. The projection takes into consideration the continuous successful ... more open approach towards cannabis products around the world. In 2016, states ... North Dakota , Ohio , and ...
(Date:3/29/2017)... 29, 2017 Research and Markets has announced ... Software Market Outlook: 2016-2022" report to their offering. ... The global patient safety ... of delivery, end-user, and geography. Patient safety has ... globe. The field has developed significantly in the last decade and ...
Breaking Medicine Technology: